vs

Side-by-side financial comparison of DORCHESTER MINERALS, L.P. (DMLP) and GERON CORP (GERN). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $41.9M, roughly 1.1× DORCHESTER MINERALS, L.P.). DORCHESTER MINERALS, L.P. runs the higher net margin — 38.7% vs -39.0%, a 77.7% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 5.4%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 16.2%).

Dorchester Minerals, L.P. is a publicly traded master limited partnership based in the United States. It acquires, owns, and manages a diversified portfolio of royalty interests, net profit interests, and mineral properties associated with oil, natural gas, and natural gas liquids production across key onshore U.S. energy basins, delivering stable cash flow returns to its unitholders.

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

DMLP vs GERN — Head-to-Head

Bigger by revenue
GERN
GERN
1.1× larger
GERN
$47.2M
$41.9M
DMLP
Growing faster (revenue YoY)
GERN
GERN
+61.6% gap
GERN
67.1%
5.4%
DMLP
Higher net margin
DMLP
DMLP
77.7% more per $
DMLP
38.7%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
16.2%
DMLP

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
DMLP
DMLP
GERN
GERN
Revenue
$41.9M
$47.2M
Net Profit
$16.2M
$-18.4M
Gross Margin
Operating Margin
-29.4%
Net Margin
38.7%
-39.0%
Revenue YoY
5.4%
67.1%
Net Profit YoY
13.7%
30.3%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMLP
DMLP
GERN
GERN
Q4 25
$41.9M
Q3 25
$35.4M
$47.2M
Q2 25
$32.4M
$49.0M
Q1 25
$43.2M
$39.6M
Q4 24
$39.7M
Q3 24
$53.5M
$28.3M
Q2 24
$37.4M
$882.0K
Q1 24
$31.0M
$304.0K
Net Profit
DMLP
DMLP
GERN
GERN
Q4 25
$16.2M
Q3 25
$11.2M
$-18.4M
Q2 25
$12.3M
$-16.4M
Q1 25
$17.6M
$-19.8M
Q4 24
$14.2M
Q3 24
$36.4M
$-26.4M
Q2 24
$23.6M
$-67.4M
Q1 24
$18.2M
$-55.4M
Operating Margin
DMLP
DMLP
GERN
GERN
Q4 25
Q3 25
-29.4%
Q2 25
-25.4%
Q1 25
-42.2%
Q4 24
Q3 24
-99.8%
Q2 24
-7860.9%
Q1 24
-18465.1%
Net Margin
DMLP
DMLP
GERN
GERN
Q4 25
38.7%
Q3 25
31.5%
-39.0%
Q2 25
38.1%
-33.4%
Q1 25
40.9%
-50.1%
Q4 24
35.9%
Q3 24
68.1%
-93.5%
Q2 24
63.2%
-7639.8%
Q1 24
58.6%
-18220.4%
EPS (diluted)
DMLP
DMLP
GERN
GERN
Q4 25
Q3 25
$-0.03
Q2 25
$-0.02
Q1 25
$-0.03
Q4 24
Q3 24
$-0.04
Q2 24
$-0.10
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMLP
DMLP
GERN
GERN
Cash + ST InvestmentsLiquidity on hand
$41.9M
$78.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.7M
Total Assets
$309.6M
$567.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMLP
DMLP
GERN
GERN
Q4 25
$41.9M
Q3 25
$41.6M
$78.1M
Q2 25
$36.5M
$77.7M
Q1 25
$41.5M
$83.7M
Q4 24
$42.5M
Q3 24
$56.5M
$60.3M
Q2 24
$35.2M
$116.9M
Q1 24
$37.7M
$189.8M
Stockholders' Equity
DMLP
DMLP
GERN
GERN
Q4 25
Q3 25
$248.7M
Q2 25
$259.5M
Q1 25
$268.2M
Q4 24
Q3 24
$292.3M
Q2 24
$306.7M
Q1 24
$344.9M
Total Assets
DMLP
DMLP
GERN
GERN
Q4 25
$309.6M
Q3 25
$330.4M
$567.4M
Q2 25
$325.6M
$555.2M
Q1 25
$349.0M
$562.5M
Q4 24
$366.8M
Q3 24
$403.4M
$444.9M
Q2 24
$176.0M
$449.4M
Q1 24
$184.8M
$482.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMLP
DMLP
GERN
GERN
Operating Cash FlowLast quarter
$34.3M
$-13.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMLP
DMLP
GERN
GERN
Q4 25
$34.3M
Q3 25
$34.3M
$-13.6M
Q2 25
$30.5M
$-27.4M
Q1 25
$33.4M
$-48.0M
Q4 24
$31.5M
Q3 24
$43.7M
$-58.9M
Q2 24
$29.4M
$-53.5M
Q1 24
$28.0M
$-62.3M
Free Cash Flow
DMLP
DMLP
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
FCF Margin
DMLP
DMLP
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Capex Intensity
DMLP
DMLP
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Cash Conversion
DMLP
DMLP
GERN
GERN
Q4 25
2.12×
Q3 25
3.07×
Q2 25
2.47×
Q1 25
1.89×
Q4 24
2.21×
Q3 24
1.20×
Q2 24
1.25×
Q1 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMLP
DMLP

Royalties$34.0M81%
Other$7.8M19%

GERN
GERN

Segment breakdown not available.

Related Comparisons